MGRX vs RJF · rev $456.0K vs rev $15.91B
Mangoceuticals, Inc. Common Stock (MGRX) versus RJF (RJF) — a side-by-side from cached financials, not a winner call.
Mangoceuticals, Inc. Common Stock (MGRX) is a health information services company listed on US.
RJF (RJF) common stock.
Latest reported MGRX revenue for 2025-12-31 was $456.0K. Net income was -$20.6M. Revenue was down 26.0% from 2024-12-31 to 2025-12-31. MGRX currently screens at market cap $16.3M.
Latest reported RJF revenue for 2025-09-30 was $15.91B. Net income was $2.13B. Revenue was up 6.6% from 2024-09-30 to 2025-09-30. RJF currently screens at market cap $0.
MGRX currently screens at market cap $16.3M. RJF currently screens at market cap $0.
Not investment advice. Open the MGRX and RJF stock pages for the full models.
Not investment advice.